Skip to main content
Log in

Progressive Atrioventricular Conduction Block in a Mouse Myotonic Dystrophy Model

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Introduction: Myotonic dystrophy is caused by expansion of a CTG trinucleotide repeat on human chromosome 19, and leads to progressive skeletal myopathy and atrioventricular conduction disturbances. A murine model of myotonic dystrophy has been designed by targeted disruption of the myotonic dystrophy protein kinase (DMPK) gene. The DMPK-deficient mice display abnormalities in A-V conduction characteristics, similar to the human cardiac phenotype. The purpose of this study was to determine whether age-related progression of A-V block occurs in a mouse model of DMPK-deficiency.

Methods and Results: Surface ECGs and intracardiac electrophysiology (EP) studies were performed in 60 immature and 90 adult homozygous (DMPK), heterozygous (DMPK), and wild-type (WT) DMPK control mice. Complete studies were obtained on 141 of 150 mice. The RR, PR, QRS, and QT intervals were measured on ECG. Sinus node recovery time, AV refractory periods, paced AV Wenckebach and 2:1 block cycle lengths, atrial and ventricular effective refractory periods were compared between genotypes and age groups. There were no differences in ECG intervals or EP findings in the young mutant mice, but progressive PR prolongation in older mice. The A-V conduction defects are also sensitive to DMPK gene dosage. Adult DMPK mice develop 1°, 2° and 3° A-V block, whereas DMPK mice develop only 1° heart block.

Conclusion: These data demonstrate that both age and DMPK dose are important factors regulating cardiac conduction in myotonic dystrophy. This mouse model of DM is remarkably similar to the human phenotype, with age-related progression in atrioventricular conduction defects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. O'Brien TA, Harper PS. Course, prognosis and complications of childhood-onset myotonic dystrophy. Devel Medicine and Child Neurol. 1984;26:62-67.

    Google Scholar 

  2. Harper PS. Myotonic Dystrophy. 2nd ed. London: WB Saunders, 1989.

    Google Scholar 

  3. Perloff JK, Stevenson WG, Roberts NK, et al. Cardiac involvement in myotonic muscular dystrophy. Am J Cardiol. 1984;54:1074-1081.

    Google Scholar 

  4. Fragola PV, Luzi M, Calo L, et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol. 1994;74:1070-1072.

    Google Scholar 

  5. Litchfield JA. A-V dissociation in dystrophia myotonica. Br Heart J. 1953;15:357-359.

    Google Scholar 

  6. Clements SD, Colmers RA, Hurst WJ. Myotonia dystrophica: ventricular arrhythmias, intraventricular conduction abnormalities, atrioventricular block and Stokes-Adams attacks successfully treated with permanent transvenous pacemaker. Am J Cardiol. 1976;37:933-935.

    Google Scholar 

  7. Prystowsky EN, Pritchett ELC, Roses AD, et al. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation 1979;60:1360-1364.

    Google Scholar 

  8. Hiromaka S, Takayudi I, Kubota K, et al. A family with myotonic dystrophy associated with diffuse cardiac conduction disturbances as demonstrated by His bundle electrocardiography. Am Heart J. 1986; 111:85-91.

    Google Scholar 

  9. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 30 end of a transcript encoding a protein kinase family member. Cell 1992; 68:799-808.

    Google Scholar 

  10. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 30 untranslated region of the gene. Science 1992;255: 1253-1255.

    Google Scholar 

  11. Fu YH, Pizzuti A, Fenwick RG, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.

    Google Scholar 

  12. Reddy S, Smith DBJ, Rich MM, et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet. 1996;13: 325-335.

    Google Scholar 

  13. Jansen G, Groenen PJTA, Bachner D, et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet. 1996;13:316-323.

    Google Scholar 

  14. Berul CI, Aronovitz MJ, Wang PJ, et al. In vivo electrophysiology studies in the mouse. Circulation 1996;94:2641-2648.

    Google Scholar 

  15. Berul CI, Maguire CT, Aronovitz MJ, et al. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest. 1999;103:R1-R7.

    Google Scholar 

  16. Berul CI, Christe ME, Aronovitz MJ, et al. Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities. J Interv Card Electrophysiol. 1998;2:7-14.

    Google Scholar 

  17. Gillette PC, Buckles DS, Harold M, et al. Intracardiac electrophysiology studies. In Pediatric Arrhythmias: Electrophysiology and Pacing. Gillette PC, Garson A, eds. WB Saunders: Philadelphia, 1990, 216-248.

    Google Scholar 

  18. Kugler JD. Electrophysiology studies. In Heart Disease in Infants, Children, and Adolescents, Including the Fetus and Young Adult. Emmanouilides GC, Reimenschneider TA, Allen HD, Gutgesell HP, eds. Williams and Wilkins: Baltimore, 1995, 347-366.

    Google Scholar 

  19. Roberts NK, Gillette PC. Electrophysiology study of the conduction system in normal children. Pediatrics 1977;60:858-863.

    Google Scholar 

  20. Saba S, Vanderbrink BA, Luciano B, et al. Localization of the sites of conduction abnormalities in a mouse model of myotonic dystrophy. J Cardiovasc Electrophysiol. 1999;10:1214-1220.

    Google Scholar 

  21. Colleran JA, Hawley RJ, Pinnow EE, et al. Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. Am J Cardiol. 1997;80:1494-1497.

    Google Scholar 

  22. Barr E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 1991;254:1507-1509.

    Google Scholar 

  23. Gussoni E, Pavlath GK, Lanctot AM, et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992;356:435-438.

    Google Scholar 

  24. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl J Med. 1995;333:832-838.

    Google Scholar 

  25. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nature Med. 1997;3:970-977.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berul, C.I., Maguire, C.T., Gehrmann, J. et al. Progressive Atrioventricular Conduction Block in a Mouse Myotonic Dystrophy Model. J Interv Card Electrophysiol 4, 351–358 (2000). https://doi.org/10.1023/A:1009842114968

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009842114968

Navigation